Dr. Guy de Bruyn, MD
Dr. Guy de Bruyn is Director for Clinical Development at Sanofi Pasteur, overseeing a large phase III vaccine trial for the prevention of Clostridium difficile infection in some 19 countries on 5 continents around the world that started in the U.S. in 2013. Previously he was a program director for HIV prevention studies in South Africa. Dr. de Bruyn earned his medical degree from the University of the Witwatersrand, South Africa and his Master’s in Public Health from the University of Washington, USA, where he was a senior fellow in the Division of Allergy & Infectious Diseases. He is a member of the American College of Physicians and the Infectious Disease Society of America.
